2m 2m 2m 2m 2m 2m 2m
AbbVie (ABBV)
NYSE
$248.10+$0.02 (+0.008%)
Price as of Jul 13, 2026 5:00 PM EDT- $441.5BMarket Cap
- 33.11%1-Year Change
- Drug Manufacturers - GeneralIndustry
AbbVie (ABBV)
$248.10+$0.02 (+0.008%)
ABBV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $248.08 | ||
Change | -$1.83 (-0.73%) | ||
Open | $251.00 | ||
High | $251.66 | ||
Low | $245.05 | ||
Previous Close | $249.91 | ||
Volume | 5,780,986 | ||
30-Day Average Volume | 9,216,560 | ||
1-Week Change | -4.98% | ||
1-Month Change | 10.28% | ||
1-Year Change | 33.11% | ||
3-Year Change | 105.40% | ||
5-Year Change | 156.69% | ||
Fundamentals | |||
Shares Outstanding | 1.8B | ||
Total Assets | $136.5B | ||
Market Cap | $441.5B | ||
Enterprise Value | $505.0B | ||
Period: QTR TTM FY | |||
Revenue | $15.0B | ||
Net Income | $695.0M | ||
Free Cash Flow | $3.6B | ||
EBIT | $1.7B | ||
EBITDA | $3.4B | ||
Net Working Capital | -$8.6B | ||
EPS | $0.39 | ||
Enterprise Value/EBITDA | 147 | ||
Enterprise Value/Revenue | 34 | ||
P/B | -66 | ||
P/E | 636 | ||
PEG | -10 | ||
Price/Free Cash Flow | 123 | ||
Price/Operating Cash Flow | 114 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.79% | ||
Trailing Annual Dividend Yield | 2.72% | ||
Ex-Dividend Date | 07/15/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield